Detection of cancer in urine

W. Frederik Rurup; Loes Segerink; Albert van den Berg; Roderik Kraaijenhagen; H.M. Pinedo; Renske Daniëla Maria Steenbergen; Jacobus Adrianus Nieuwenhuijzen; Idris Bahce; Geert Kazemier

Detection of cancer in urine

W. Frederik Rurup^* (Inventor)
, Loes Segerink^* (Inventor)
, Albert van den Berg (Inventor)
, Roderik Kraaijenhagen (Inventor)
, H.M. Pinedo (Inventor)
, Renske Daniëla Maria Steenbergen (Inventor)
, Jacobus Adrianus Nieuwenhuijzen (Inventor)
, Idris Bahce (Inventor)
, Geert Kazemier (Inventor)

^*Corresponding author for this work

Research output: Patent

Abstract

The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample.

Original language	English
Patent number	11821040
IPC	16089222
Filing date	21/11/23
Publication status	Published - 21 Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{1377be591fa9414ba8dca6241407caa5,

title = "Detection of cancer in urine",

abstract = "The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample.",

author = "Rurup, \{W. Frederik\} and Loes Segerink and \{van den Berg\}, Albert and Roderik Kraaijenhagen and H.M. Pinedo and Steenbergen, \{Renske Dani{\"e}la Maria\} and Nieuwenhuijzen, \{Jacobus Adrianus\} and Idris Bahce and Geert Kazemier",

year = "2023",

month = nov,

day = "21",

language = "English",

type = "Patent",

note = "11821040; 16089222",

}

TY - PAT

T1 - Detection of cancer in urine

AU - Rurup, W. Frederik

AU - Segerink, Loes

AU - van den Berg, Albert

AU - Kraaijenhagen, Roderik

AU - Pinedo, H.M.

AU - Steenbergen, Renske Daniëla Maria

AU - Nieuwenhuijzen, Jacobus Adrianus

AU - Bahce, Idris

AU - Kazemier, Geert

PY - 2023/11/21

Y1 - 2023/11/21

N2 - The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample.

AB - The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample.

M3 - Patent

M1 - 11821040

Y2 - 2023/11/21

ER -

Detection of cancer in urine

Abstract

UN SDGs

Fingerprint

Cite this